Introduction
============

Leishmaniasis refers to a spectrum of human diseases caused by protozoan parasites belonging to the genus *Leishmania*, subgenus either *Leishmania* or *Viannia*. All forms of leishmaniasis are initiated when the promastigote form of the parasite is introduced into the skin of a mammalian host during a sand fly bite, after which they enter local phagocytic cells. Thereafter, parasites convert to their intracellular amastigote form and reside intracellularly. Most parasites reside in host macrophages throughout chronic infection. Amastigotes multiply and spread to new phagocytes, disseminating through host tissues in a pattern dictated primarily by the particular species of the organism. Productive infections may be either asymptomatic, or lead to different clinical syndromes involving internal organs, skin and/or mucosal surfaces ([@B4]; [@B49]).

*Leishmania braziliensis*, a member of the *Leishmania* and *Viannia* sub-genus, is prevalent in Latin America. *L. braziliensis* causes at least three clinical types of tegumentary disease: localized cutaneous (CL), mucosal (ML), and disseminated leishmaniasis (DL) ([@B18]; [@B11]; [@B4]; [@B5]; [@B64]; [@B49]). The most striking feature differentiating CL from either ML or DL is the degree of metastasis of the microorganism, with consequent disease manifestations limited to or distant from the original inoculation site. Localized cutaneous leishmaniasis causes ulcerated lesions restricted to the parasite entry site in the skin, whereas ML is defined by spread of lesions to non-adjacent mucosal surfaces of upper digestive and airways tracts. DL is characterized by parasite dissemination causing lesions throughout skin sites of the infected patient ([@B39]).

Individuals living in the region of Corte de Pedra in the state of Bahia, Northeast Brazil, can be afflicted with any of the above three phenotypes of *L. braziliensis* disease.

With the current study we want to follow up our prior observation that *L. braziliensis* isolates derived from individuals with different clinical syndromes can be distinguished by polymorphic markers in the *L. braziliensis* genome, and these markers distinguish separate clades of *L. braziliensis* ([@B62]; [@B53]; [@B28]). We have used this information to track parasite isolates during their movement through time and geographic parts of endemic areas ([@B62], [@B61]). The goal of the current study was to discern whether these genotypic differences lead to detectable differences in host macrophage responses. Because the earliest responses seem to be critical in leishmaniasis, we used a model that would be most relevant to initial infection of a naïve host with *L. braziliensis*. Three clades corresponding to each of the predominant forms of tegumentary leishmaniasis in the region were studied. Specifically, clade A contains primarily isolates from individuals with DL, clade B contains isolates from CL subjects, and isolates from individuals with ML are concentrated in clade C ([@B62]).

Successful infection and ultimate dissemination of microorganisms throughout the host likely depends, in part, on the very early parasite--host cell interactions. Other studies have documented different patterns of gene expression in host macrophages after phagocytosis of different *Leishmania* species ([@B16]; [@B21]). Due to the severity and the diverse clinical forms of disease caused by *L. braziliensis*, we hypothesized that macrophage responses to the *Leishmania* subgenus *Viannia* *braziliensis* might be unique, and that these responses may differ between infections initiated by the distinct clades of *L. braziliensis*. The purpose of the current study, therefore, was to characterize and compare the initial changes in macrophage gene expression after phagocytosis of the three distinct *L. braziliensis* isolates from the three different clades. Similar to other investigators, we chose to focus on changes that occur at the earliest steps of infection based on the assumption that the patterns of gene expression at the very onset of infection initiate the environment that locally lead to the immunopathologic changes that occur later in disease.

Materials and Methods {#s1}
=====================

Parasites
---------

*Leishmania braziliensis* isolates were originally derived from individuals with CL, ML, or DL diagnosed in the medical clinic in Corte de Pedra, Bahia, Brazil. The three types of leishmaniasis were defined are as follows. Localized cutaneous leishmaniasis consisted of an ulcerated skin lesion at a single body site with no more than two secondary or satellite lesions, without clinical evidence of mucosal involvement. Mucosal leishmaniasis was defined as the presence of an inflamed or ulcerated mucosal lesion at a site that was non-contiguous with any cutaneous lesion. ML most frequently involved the nasal septum, oropharyngeal cavity, and/or larynx. Disseminated leishmaniasis was defined as 10 or more skin lesions of mixed type (acneiform, papular, nodular, and/or ulcerated) located in two or more body parts (head, trunk, arms, and legs). A diagnosis of tegumentary leishmaniasis was made by isolation of parasites in culture from an aspirate or biopsy of a cutaneous or mucosal lesion. Additionally, all patients had a positive delayed hypersensitivity skin response to leishmania antigen (Montenegro Test).

*Leishmania braziliensis* isolates used in the present study were cultured from aspirates of lesion borders suspended in liver infusion tryptose/Novy, McNeal, Nicolle (LIT/NNN) medium then expanded in Schneider's medium complemented with 10% heat inactivated fetal calf serum and 2 mM [L]{.smallcaps}-glutamine. Species determination was based upon HSP-70 PCR-RFLP ([@B23]; [@B45]) and confirmed by real time PCR ([@B66]). Parasites were frozen in 10% DMSO, 90% growth medium in liquid nitrogen and thawed prior to macrophage infection studies. All studies were conducted with parasites in stationary phase of growth.

Human Studies Approvals
-----------------------

Studies were approved by Institutional Review Boards of the Federal University of Bahia (document of approval: CAAE-- 3041.0.000.054.07) and The University of Iowa. Study subjects were healthy adults over age 18, and written consent was obtained from all of them.

Macrophages and Macrophage Infections
-------------------------------------

Peripheral blood mononuclear cells were isolated from normal healthy male volunteers from Salvador, Brazil, who resided outside of regions endemic for *L. braziliensis* infection. Monocytes were separated from peripheral blood by Ficoll hypaque density sedimentation, and adherence to plastic. Cells were maintained in Teflon vials in 20% autologous serum, 2 mM [L]{.smallcaps}-glutamine in RPMI 1640 with 100 U/ml penicillin and 100 μg/ml streptomycin (reagents from GIBCO). After a 5 days culture at 37°C and 5% CO~2~, differentiated monocyte-derived macrophages (MDMs) were suspended in 10% heat-inactivated fetal calf serum (Sigma-Aldrich, St. Louis, MO, United States), 2 mM [L]{.smallcaps}-glutamine in RPMI 1640 with 100 U/ml penicillin and 100 μg/ml streptomycin (Gibco/ThermoFisher, Waltham, MA, United States) \[RP-10\] and allowed to adhere to glass coverslips for 4 h at 37°C and 5% CO~2~. Non-adherent cells were removed by rinsing, then adherent MDMs were incubated overnight in RP-10 at 37°C, 5% CO~2~.

Monocyte-derived macrophages from each of four donors were incubated in RP-10 with stationary phase *L. braziliensis* promastigotes from each of the three clades at a 2:1 parasite:MDM ratio. Incubations were synchronized by centrifugation at 60 ×*g* for 4 min at 4°C, and transferred to 37°C, 5% CO~2~. The synchronization step greatly enhances the efficiency of parasite infection, enabling experiments to achieve infection of a majority of MDMs on the coverslip ([@B55]). Control MDMs were treated in parallel but parasites were not added. After 1 h, free parasites were removed by rinsing and the RP-10 cultures were returned to 37°C, 5% CO~2~ for an additional 3 h.

Duplicate coverslips from MDM-parasite co-cultures were removed, fixed in methanol and stained with Wright Giemsa (Diff Quik Hema 3, Fisher Scientific) to document the parasite loads. From the remaining samples, total RNA was extracted with Trizol (Invitrogen, Carlsbad, CA, United States). RNA was treated with DNaseI and purified with Qiagen RNeasy mini-kit (Qiagen, Hilden, Germany). The RNA quality was checked with the Agilent Model 2100 Bioanalyzer (Agilent Technologies, Palo Alto, CA, United States). The numbers of MDMs with internalized parasites were quantified microscopically. Sets of samples from a single donor in which all three infected conditions contained at least 80% of the macrophages with intracellular parasites, and in which all four conditions generated highly pure RNA, were chosen for microarrays.

Microarrays
-----------

cDNA was generated from 50 ng of total RNA and amplified with SPIA, a small sample PCR-based isothermal amplification method, using the Ovation Pico RNA Amplification System, v2 (NuGEN Technologies, Cat. \#3100) according to the manufacturer's protocol. The amplified SPIA cDNA product was purified through a QIAGEN QIAquick PCR Purification column (QIAGEN Cat \#28104), according to modifications from NuGEN, then 3.75 μg of this product were fragmented (average fragment size = 85 bases) and biotin labeled using the NuGEN FL-Ovation cDNA Biotin Module, v2 (NuGEN Technologies, Cat. \#4200) per the manufacturer's protocol. The resulting biotin-labeled cDNA was hybridized to the Human U133+2.0 arrays (Cat \#900470) at 45°C for 18 h. Arrays were washed and subject to secondary labeling with fluorescent probes per the Affymetrix protocols. Arrays and associated procedures were performed at The University of Iowa DNA Core facility.

After quality assessment using *affyQCReport* ([@B24]), data were imported into Partek (PartekGS, St. Louis, MO, United States) and normalized using gcRMA ([@B30]). Arrays were compared by both ANOVA and paired *t*-test models, using the Partek batch correction feature to correct for the different hybridization sets. Significance was assessed based on *p*-value with step-up FDR multiple testing correction and fold change cutoffs. Identification of cellular pathways possibly affected in macrophages by infection with parasites was carried out using Ingenuity Pathway Analysis (IPA, QIAGEN). All transcript abundance results consist in the positive or negative fold change (i.e., ratio) in the expression of the genes in infected as compared to non-infected MDMs.

The affymetrics DNA micro array chip includes internal controls of base line gene expression across samples, that include GAPDH and β-actin, besides a number of internal positive and negative controls at the edges of the chip. This allows the 'affyQCReport' software tool to assess basal gene expression level within and between chips, using the GAPDH/β-actin expression ratios, and to evaluate the uniformity of test cDNA hybridization, and thus the expression reading throughout the entire chip area. Only those experiments that passed these tests were further analyzed in this study.

Validation of Selected Changes in Gene Expression
-------------------------------------------------

Transcripts selected for validation were significantly expressed in all samples, and changes in gene expression were statistically significant considering all four replicate samples in microarrays by ANOVA. Changes in expression observed on microarrays were validated by reverse transcriptase followed by qPCR to document gene expression in RNA samples from replicate MDM samples incubated without or with the representatives of *L. braziliensis* clades. cDNA was generated using the Superscript III First Strand Synthesis System kit (Invitrogen/ThermoFisher, Waltham, MA, United States) and random hexamers, followed by RNase H treatment according to the manufacturer's instructions. Taqman and primer pairs for qPCR were purchased from Applied Biosciences, Inc. (ABI, Foster City, CA, United States). Data were analyzed using the ΔΔCT method ([@B63]).

Statistical Analyses Other Than Microarrays
-------------------------------------------

Differences in the percent of macrophages infected, or in the numbers of intracellular parasites per infected macrophage between the clades were compared using chi-square or one-way ANOVA, respectively. RT-qPCR expression data were analyzed for significant changes between donors using ANOVA. Changes in expression of individual transcripts were tested for significance by paired *t*-test. Comparisons of gene expression profiles between clades employed Friedman's and paired one-tailed Wilcoxon tests. For experiments other than microarrays, comparisons were considered significant at *p* \< 0.05. Statistical analyses were performed with either Partek or Prism GraphPad software.

Results
=======

MDM Infections
--------------

Peripheral blood monocyte derived macrophages from four human donors were incubated *in vitro* with medium alone, or with each of three strains of *L. braziliensis* representative of clades A, B, or C under conditions promoting parasite phagocytosis. The three parasite strains used for all infections included one derived from an individual with CL (clade B), one from an individual with ML (clade C) and one from a subject with DL (clade A). Considering our prior observation that the 4 h time was optimal for microarray studies using *L. infantum* ([@B21]), we chose the 4 h time point to compare responses to different strains of *L. braziliensis.* **Figure [1](#F1){ref-type="fig"}** shows that a large proportion of the MDMs contained intracellular parasites (**Figure [1A](#F1){ref-type="fig"}**; clade A 83 ± 5%, clade B 81 ± 8%, clade C 81 ± 7%, mean ± SD), with a mean of 5 parasites in each cell (**Figure [1B](#F1){ref-type="fig"}**; clade A 5.0 ± 0.6, clade B 5.6 ± 1.1, clade C 5.3 ± 1.4, mean ± SD). Neither the percent of MDMs infected nor the number of intracellular parasites per macrophage differed statistically between donors or between parasite clades within each donor (chi-square and one-way ANOVA, respectively).

![Parasite loads in infected MDMs used for microarrays. **(A)** The percentage of macrophages infected at a 2:1 (parasite:macrophage) ratio for 4 h with each isolate of *Leishmania braziliensis* from clades A, B, or C was quantified microscopically in four replicated donors (chi-square, *p* \> 0.05). **(B)** Mean number of intracellular *L. braziliensis* parasites per infected macrophage in A (one-way ANOVA, *p* \> 0.05). **(C)** Kinetics of the proportion of macrophages infected with isolates of *L. braziliensis* from clades A or B in four replicated donors, at a 2:1 (parasite:macrophage) ratio for 30 min to 48 h (chi-square from 4 to 48 h data points, *p* \> 0.05). **(D)** Kinetics of the mean number of intracellular *L. braziliensis* parasites per infected macrophage in C (one-way ANOVA, *p* \< 0.05; Pearson's correlation, *R*^2^= 0.93, *p* = 0.037, for data combined between clades A and B parasites represented in the figure versus time post-infection). Data show mean ± SE after quantifying at least 400 macrophages per condition in MDMs from each donor.](fmicb-09-02464-g001){#F1}

We then checked changes in levels of MDM infections overtime. The proportion of MDM infected with *L. braziliensis* peaked at 4 h and remained constant up to 48 h, when last assessed (**Figure [1C](#F1){ref-type="fig"}**; chi-square, *p* \> 0.05). However, the numbers of parasites per infected MDM continuously increased throughout the kinetics experiment (**Figure [1D](#F1){ref-type="fig"}**; one-way ANOVA, *p* \< 0.05; Pearson's correlation, *R*^2^= 0.93, *p* = 0.037, for data combined between clades A and B parasites represented in the figure versus time post-infection).

Global Changes in Gene Expression Among Infected MDM
----------------------------------------------------

All transcripts that were significantly expressed in infected MDMs were considered in our analyses. Data were first analyzed within each donor for the change in expression between the infected versus the uninfected MDM conditions for each clade. Transcripts that were statistically significantly changed considering all four donors were determined using ANOVA with FDR multiple testing correction. Changes in gene expression induced by the three different clades in all four donors were compared using ANOVA. All transcripts noted in this report were selected because of a significance level of at least *p* \< 0.0001. Most changes were at least twofold (i.e., Log~2~ = 1.0), with exceptions noted in specific instances.

Most transcripts were unchanged by infection, as expected. Examples of transcripts encoding proteins relevant to cellular functions that did not change in macrophages infected with any of the three clades included MTCH2 (mitochondrial carrier 2; overall *p* = 0.9562), TLL5 (tubulin tyrosine ligase-like family, member 5; overall *p* = 0.9556) and PLOD2 (procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2; overall *p* = 0.9552) amongst many others.

More than 500 expressed transcripts were significantly changed to the *p* \< 0.0001 level upon infection with any of the three strains of *L. braziliensis*. A comprehensive list of transcripts that changed and met the above significance criteria can be found in the **Supplementary Table [1](#SM1){ref-type="supplementary-material"}**. Among the 576 altered transcripts, 487 were altered in macrophages infected with clade A, 156 in macrophages infected with clade B and 318 in macrophages infected with clade C. Considering all the transcripts whose abundance changed by the significance criteria, 471 transcripts were down-regulated whereas 89 were up-regulated. Significantly altered transcripts were classified according to functional pathways. The host processes affected by *L. braziliensis* phagocytosis distributed into four main categories: signal propagation, mitochondrial function, apoptosis, and response to external environment. The predominant pathways and genes whose expression was altered by *L. braziliensis* infection, and the changes in expression for each clade, are listed in **Table [1](#T1){ref-type="table"}**.

###### 

Examples of human monocyte derived macrophage genes whose expression was significantly changed by infection with *L. braziliensis* belonging to clades A, B, or C from Corte de Pedra (Statistical analyses by one-way ANOVA).

  Functional group                 Gene       *p*-Value      Log~2~ change in expression relative to uninfected MDMs   Gene description                        
  -------------------------------- ---------- -------------- --------------------------------------------------------- ------------------ ------ ------ ------ ------------------------------------------------------------------------
  **Decreased expression**                                                                                                                                     
  **Signal propagation**                                                                                                                                       
  Surface receptors                TLR8       9.15004e-005   0.0017291                                                 8.18538e-005       -2.5   -1.9   -2.5   Toll-like receptor 8
                                   IL-12RB1   5.44261e-005   0.000572767                                               0.00147462         -1.8   -1.5   -1.5   Interleukin 12 receptor, beta one subunit
                                   IL-15RA    2.01434e-005   0.000597875                                               0.000135149        -2.2   -1.7   -1.9   Interleukin 15 receptor, alpha subunit
  Signal transduction              MYD88      3.33232e-005   0.000460159                                               0.000161814        -1.7   -1.5   -1.6   Myeloid differentiation primary response (88); Activates NF-kB
                                   PELI1      0.000140615    0.00015842                                                4.70314e-005       -1.9   -1.9   -2.1   Pellino-related intracellular-signaling molecule; Activates NF-kB
                                   ECT2       6.22083e-005   0.000954735                                               0.00019954         -2.6   -2.0   -2.3   Epithelial cell transfer sequence 2 oncogene; Activates NF-kB
                                   VISA       0.000291381    4.07134e-005                                              0.000187217        -1.7   -2.0   -1.8   Virus-induced signaling adapter; Activates NF-kB
                                   NOD2       3.23249e-005   9.92379e-006                                              1.90858e-005       -2.4   -2.7   -2.5   Nuclear-binding oligomerization domain contining 2; Activates NF-kB
                                   STAT1      6.06884e-005   0.00179476                                                3.96141e-005       -1.4   -1.2   -1.4   Signal transduction and activation of transcription 1 JAK-STAT pathway
                                   STAT5A     3.97644e-005   0.00148146                                                0.000634802        -1.6   -1.4   -1.4   Signal transduction and activation of transcription 5 JAK-STAT pathway
                                   TYK2       2.32594e-005   0.000160678                                               3.71196e-005       -1.8   -1.6   -1.7   Non-receptor member of JAK family; JAK-STAT pathway
                                   JAK2       2.8929e-005    6.75267e-005                                              1.48982e-005       -2.2   -2.1   -2.4   Janus kinase 2; JAK-STAT pathway
                                   MAP2K5     0.00868219     0.000126235                                               9.53199e-006       -1.2   -1.5   -1.7   Mitogen-activated protein kinase kinase 5; MAPK pathway
                                   MAP2K3     6.23796e-005   0.000128993                                               6.32058e-005       -1.9   -1.8   -1.9   Mitogen-activated protein kinase kinase 3; MAPK pathway
                                   ICK        7.68298e-005   0.000600357                                               3.15881e-005       -2.3   -1.9   -2.5   Intestinal cell (MAK-like) kinase; Possibly MAPK pathway
                                   TRAF7      2.50164e-005   0.000317723                                               0.0002048          -1.4   -1.3   -1.3   TNF receptor-associated factor 7; MKKK of MAPK pathway
                                   PLCB2      1.7885e-005    5.43495e-005                                              3.08817e-006       -1.7   -1.6   -1.9   Phospholipase C, beta 2 chain; Activates Phospholipase C
                                   CAMKK2     8.90843e-006   0.000102443                                               1.61629e-005       -1.9   -1.6   -1.8   Calcium/calmodulin-dependent protein kinase kinase 2
                                   MFNG       4.41145e-005   0.00259564                                                0.00011307         -1.9   -1.5   -1.8   Manic fringe; Notch signaling pathway
  **Transcriptional regulators**   TRERF1     4.08183e-005   0.00106701                                                0.000153032        -1.9   -1.6   -1.5   Transcriptional regulator
  **Nuclear pore function**        XPO6       7.73493e-005   0.000158596                                               3.54427e-005       -1.5   -1.5   -1.6   Exportin 6; nuclear pore protein transporter
                                   RANBP10    2.96201e-005   0.000235132                                               0.000147206        -2.0   -1.7   -1.8   RAN binding prot 10; nuclear pore transport
                                   NUP62      4.25576e-005   0.000737207                                               0.000128261        -1.4   -1.3   -1.4   Nucleoporin 62 kDa
                                   NUP93      6.71235e-005   0.00070184                                                0.000213948        -1.6   -1.4   -1.5   Nucleoporin 93 kDa
                                   NUP214     1.07315e-005   0.00204607                                                0.00011174         -1.8   -1.3   -1.6   Nucleoporin 214 kDa
  **Mitochondrial function**                                                                                                                                   
  Electron transport               ISCU       5.90789e-006   4.1835e-005                                               1.09868e-005       -1.5   -1.4   -1.5   Iron--sulfur cluster scaffold homolog
                                   ISCA2      1.49189e-005   0.000379011                                               2.9555e-005        -2.4   -1.8   -2.3   Iron--sulfur cluster assembly 2 homolog
                                   NDUFA11    1.61998e-005   0.000285867                                               7.42091e-006       -1.4   -1.3   -1.4   NADH dehydrogenase subunit, mitochondrial encoded
                                   NDUFC1     3.5465e-005    0.000959163                                               4.37207e-005       -1.4   -1.3   -1.4   NADH dehydrogenase subunit, mitochondrial encoded
                                   NDUFB10    9.64108e-006   0.000432758                                               5.43291e-005       -1.5   -1.3   -1.4   NADH dehydrogenase subunit, mitochondrial encoded
                                   NDUFV3     4.55964e-006   0.000170585                                               1.11309e-005       -1.8   -1.5   -1.7   NADH dehydrogenase subunit, mitochondrial encoded
                                   NDUFS3     3.86571e-007   1.31216e-005                                              8.56046e-007       -1.6   -1.4   -1.5   NADH dehydrogenase subunit, mitochondrial encoded
                                   NDUFS2     3.55512e-005   0.000983593                                               0.000288838        -1.7   -1.4   -1.5   NADH dehydrogenase subunit, mitochondrial encoded
                                   NDUFB8     8.34828e-005   0.000590415                                               0.0012524          -1.3   -1.2   -1.2   NADH dehydrogenase subunit, mitochondrial encoded
                                   TFAM       3.42623e-005   0.00349217                                                8.02956e-005       -1.5   -1.3   -1.5   Transcription factor A, mitochondrial; encoded in the nucleus
  Mitochondrial protein            MRPS14     8.24489e-005   0.000132693                                               0.000467884        -2.3   -2.2   -2.0   Mitochondrial ribosomal protein S14; encoded in the nucleus
  synthesis                        MRPS35     1.0742e-005    0.00014928                                                1.28405e-005       -1.5   -1.4   -1.5   Mitochondrial ribosomal protein S35; encoded in the nucleus
                                   MRPL16     2.17496e-005   0.000230342                                               8.89629e-005       -2.0   -1.7   -1.8   Mitochondrial ribosomal protein L16; encoded in the nucleus
                                   MRPL19     0.000265737    0.00231705                                                7.0312e-005        -1.8   -1.5   -1.9   Mitochondrial ribosomal protein L19; encoded in the nucleus
                                   MRPL41     4.5838e-005    0.00148749                                                0.000301997        -1.7   -1.4   -1.5   Mitochondrial ribosomal protein L41; encoded in the nucleus
                                   MRPL52     7.55371e-005   0.00318154                                                0.00012328         -1.5   -1.3   -1.5   Mitochondrial ribosomal protein L52; encoded in the nucleus
                                   MRP63      8.37002e-005   0.00353342                                                0.000356301        -1.6   -1.4   -1.5   Mitochondrial ribosomal protein 63; encoded in the nucleus
                                   PDHB       8.56049e-005   0.00209902                                                0.000120183        -1.8   -1.5   -1.7   Pyruvate dehydrogenase (lipoamide) beta
  **Apoptosis**                                                                                                                                                
                                   TP53       0.000833372    0.0018592                                                 7.78129e-005       -1.5   -1.5   -1.8   Tumor protein p53; Tumor suppressor
                                   MAPK14     2.07957e-005   0.000172754                                               5.78548e-005       -1.7   -1.5   -1.6   Phosphorylates and activates TP53
                                   FRAP1      7.21564e-005   0.000895603                                               0.000148447        -2.2   -1.8   -2.0   Phosphorylates and activates TP53
                                   YPEL3      1.10105e-005   0.000141583                                               2.17379e-005       -2.9   -2.2   -2.7   Tumor suppressor directly induced by TP53
                                   MRPL41     4.5838e-005    0.00148749                                                0.000301997        -1.7   -1.4   -1.5   TP53 translocation to mitochondrion
  **Parkinson's disease**                                                                                                                                      
                                   LRRK2      0.000111713    0.00051427                                                7.7878e-005        -3.9   -3.1   -4.1   PARK8; Induces apoptosis; Interacts with PARKIN and DJ-1
                                   DJ-1       8.46957e-006   0.0013984                                                 0.000116928        -1.3   -1.2   -1.2   PARK7; Redox-sensitive chaperone and sensor of oxidative stress
                                   NUB1       0.000155931    0.000373989                                               6.53521e-005       -1.7   -1.6   -1.7   Negative regulator of ubiquitin-like proteins 1; Part of Lewy bodies
  **Increased expression**                                                                                                                                     
  **Transcriptional regulation**   HIC1       5.26337e-005   0.000501033                                               0.00023281         3.6    2.7    2.9    Transcription repressor Hypermethylated in Cancer 1
  **Apoptosis**                    ETS2       4.80848e-005   0.000607089                                               0.000184372        2.4    1.9    2.1    Probably transcriptional activator of TP53
  **Proteasomal degradation**                                                                                                                                  
                                   UBC        7.4032e-005    0.00237149                                                0.000111829        1.2    1.1    1.2    Ubiquitin C; proteasome
                                   UBAP1      3.48504e-005   0.000293469                                               0.000225023        1.5    1.4    1.4    Ubiquitin associated protein 1 target ubiquitinilation
                                   SPSB1      7.87991e-005   0.000339641                                               0.000157297        2.4    2.1    2.2    Substrate recognition-E3 ubiquitin--protein ligase complex
                                   KLHL21     5.79205e-005   0.000134488                                               3.97511e-005       1.7    1.6    1.7    Kelch-like 21; Adapter of an E3 ubiquitin-protein ligase complex
                                   USP12      9.3778e-005    0.000972177                                               0.000104449        1.6    1.4    1.5    Ubiquitin specific peptidase 12; Deubiquitinating enzyme
  **Environmental response**                                                                                                                                   
  Metal binding                    MT1M       9.05665e-005   0.000215829                                               2.07091e-005       7.6    6.3    11.0   Metallothionein 1M
                                   MT1X       0.000232234    0.000598304                                               5.30768e-005       2.7    2.4    3.2    Metallothionein 1X
                                   MT1F       0.000211204    0.000573519                                               4.83875e-005       2.6    2.4    3.2    Metallothionein 1F
                                   MT1E       8.88948e-006   2.39768e-005                                              2.1035e-006        3.4    3.0    4.2    Metallothionein 1E
                                   MT1G       1.43444e-006   6.48199e-006                                              4.16245e-007       2.7    2.4    3.1    Metallothionein 1G
                                   MT1H       1.17455e-005   4.00175e-005                                              3.2461e-006        2.7    2.4    3.1    Metallothionein 1H
  Antioxidant response             TXNRD1     5.75177e-006   6.15629e-006                                              2.27237e-006       1.3    1.3    1.4    Thioredoxin reductase 1
  Stress response                  HSPA1A     7.71182e-005   0.000256787                                               5.82824e-005       5.8    4.6    6.1    Heat shock 70 kDa protein 1A

Down-Regulated MDM Transcripts
------------------------------

The overwhelming majority (84.2%) of transcripts that were significantly altered by infection with any of the three *L. braziliensis* clades were repressed (**Figure [2](#F2){ref-type="fig"}**). Selected noteworthy transcripts, and *p*-values for each listed transcript (ANOVA), are displayed in **Table [1](#T1){ref-type="table"}**. Genes belonging to three of the four categories mentioned above were predominantly down-regulated. The category with the largest number of significantly down-regulated transcripts encoded components of cellular signaling pathways. These included mRNAs encoding cell surface receptors, signal transduction proteins and one transcriptional regulator. Transcripts encoding nuclear permeability factors were also diminished.

![Global changes in infected MDM gene expression. MDMs from four healthy human donors were infected at a 2:1 (parasite:MDM) ratio with each of three isolates of *L. braziliensis* from clades A, B, or C ([@B62]). The clades A, B, and C isolates were drawn from patients with DL, CL, and ML, respectively. After 4 h, total RNA was extracted and processed for hybridization to Affymetrix human transcript microarrays. Fold changes were calculated by comparing fluorescence data representing the abundance of each transcript in infected versus uninfected MDMs from the same donor. Each dot in the figure represents the average fold change in abundance of each transcript in all four donors. Eighty-nine transcripts were significantly increased, and 471 transcripts were significantly decreased after MDM infection with each of the three *L. braziliensis* isolates (one-way ANOVA for repressed transcripts among MDM infected with clades A, B, or C, *p* \< 0.0001).](fmicb-09-02464-g002){#F2}

The most highly repressed transcript encoding a cell surface receptor was Toll-like receptor 8, the receptor that senses single stranded RNA within the host cell. Also affected was the transcript for MyD88, a binding protein necessary for function of many TLRs, including TLR8 ([@B35]). Transcripts encoding cytokine receptors or signaling intermediates in cytokine-initiated cascades that were down-modulated included subunits of receptors for IL-12 (IL12Rβ1), IL15 (IL15Rα), and IL-10 (IL10Rβ). Proteins transducing signals from cytokine receptors were also down-regulated, most notably Jak2, STAT1, STAT5A, TYK2, and two MAP kinase kinases (MAP2K5 and MAP2K3). Both the TLR and Jak-STAT pathways can converge on the transcription factor NF-κB ([@B51]); thus these modifications could result in diminished pro-inflammatory responses. Overall, forty transcripts encoding signaling intermediates or transcriptional regulators were significantly affected at a *p* \< 0.0001 level, and 35 of these (87.5%) were down-regulated. Surprisingly, transcripts encoding components of nuclear pores were also down-modulated by *L. braziliensis* infection, including two transcripts encoding Ran binding proteins (nuclear exportin 6, XPO6; and RBP10) and three nucleoporins (NUP62, NUP93, and NUP214).

Several transcripts encoding proteins that function in the mitochondrion were significantly decreased. These included proteins important for mitochondrial oxidative phosphorylation. The down-modulated nuclear-encoded proteins ISCU and ISCA2 are two of the three peptides that are translocated into the mitochondrion to serve as scaffold proteins for the biogenesis of iron--sulfur clusters ([@B56]). These clusters are involved in electron transfer chains of both Complex I and Complex II during oxidative phosphorylation. In addition to the above, expression of all seven mitochondrially-encoded subunits of the NADH dehydrogenase constituting Complex I were significantly suppressed, possibly decreasing essential components of the mitochondrial electron transport chain ([@B3]). Transcripts encoding additional proteins responsible for mitochondrial protein synthesis were also suppressed, including one of two subunits of the major mitochondrial transcription factor TFAM and seven mitochondrial ribosomal proteins (MPRS 14, 35; MPRL 16, 19, 41, 52; MRP 63). Complex I and other mitochondrial proteins are essential for translocating protons across the mitochondrial inner membrane and generating the electrochemical potential gradient necessary for ATP production, generation of reactive oxygen species, and promoting apoptosis ([@B17]). Thus, the above observations could have implications for macrophage programmed cell death, as well as cellular metabolic activity.

Other transcripts involved in the intrinsic apoptosis pathway ([@B31]) that were suppressed by *L. braziliensis* exposure included TP53, which encodes tumor protein 53 or p53, and LRRK2, the major late-onset familial Parkinson's disease associated gene \[also called PARK 8 ([@B52]; [@B69])\]. Expression of proteins that participate in p53 function were also decreased: MAPK14 and FRAP1 phosphorylate and activate p53; YPEL3 is induced by p53; MRPL41 stabilizes p53 and enhances its translocation into the mitochondrion ([@B34]). LRRK2 (PARK 8) is hypothesized to play a role upstream of the MAPK pathway and to mediate both familial and sporadic Parkinson's disease by inducing intrinsic neuronal apoptosis ([@B69]; [@B29]; [@B36]). Other genes that associate with Parkinson's disease that were also repressed were NUB1 which encodes a Lewy body protein, and DJ-1 (aka PARK7) whose product can bind LRRK2 and is associated with a recessive form of Parkinson's disease ([@B8]).

Up-Regulated MDM Transcripts
----------------------------

Only 15.8% of transcripts significantly influenced by MDM infections were up-regulated (**Figure [2](#F2){ref-type="fig"}** and **Table [1](#T1){ref-type="table"}**). Noteworthy up-regulated transcripts include the negative regulator of transcription HIC1, and a transcription factor activating the apoptosis protein TP53, ETS2 ([@B65]). It is possible that the latter was induced in response to down-regulated expression of TP53 itself. Many of the other up-regulated transcripts encoded genes involved in response to environment conditions, sometimes involved in the cellular response to stress. Similar to our prior report, transcripts encoding several metallothionein proteins were highly up-regulated ([@B21]). Metallothioneins are important for metal chelation and regulating cellular content of zinc. Because of their high cysteine content, metallothioneins not only chelate metal ions, but in some situations they can play a protective role against oxidant toxicity ([@B50]). The transcript for thioredoxin reductase was also increased, as was the transcript of the HSP70 family member HSPA1A. Several transcripts encoding proteins associated with ubiquitin targeting were increased, suggesting an increase in proteins acting as chaperones for misfolded or damaged proteins targeted for degradation in the proteasome ([@B67]).

Validation of Micro-Array Findings
----------------------------------

Selected microarray findings were validated in two manners. First, amongst the transcripts that were significantly changed by *L. braziliensis* infection, some were chosen for validation using the original mRNAs employed in microarray hybridization. The transcripts were chosen to reflect a spectrum ranging from highly induced to highly repressed. Validation of mRNA changes was done by reverse transcriptase-qPCR. The mean fold changes according to each method are shown in **Table [2](#T2){ref-type="table"}**. In all 30 conditions evaluated by RT-qPCR, the relative abundance of transcripts changed in the same direction as the microarray. Not surprisingly, there were differences in the magnitude of fold change between the two methods. Nonetheless the 10 transcripts fell into the same approximate rank order from highest to lowest fold change in expression, differing in order by 0--2 positions when aligned according to microarray versus RT-qPCR data.

###### 

Changes in expression of 10 transcripts in MDMs infected with *L. braziliensis* isolates belonging to each clades (A, B, or C) were documented in independent assays of gene expression in four MDM donors.

  Transcript   Clade   Fold change   
  ------------ ------- ------------- -------
  MT1M         A       7.653         2.660
  MT1M         B       6.269         2.405
  MT1M         C       11.048        4.945
  HSPA1A       A       5.763         4.869
  HSPA1A       B       4.563         3.249
  HSPA1A       C       6.101         4.414
  MT1X         A       2.662         3.880
  MT1X         B       2.384         2.898
  MT1X         C       3.203         5.642
  TXNRD1       A       1.337         1.524
  TXNRD1       B       1.334         1.560
  TXNRD1       C       1.377         1.855
  UBC          A       1.179         1.444
  UBC          B       1.111         1.283
  UBC          C       1.170         1.351
  DJ-1         A       0.406         0.843
  DJ-1         B       0.435         0.949
  DJ-1         C       0.435         0.985
  TRERF1       A       0.268         0.453
  TRERF1       B       0.330         0.486
  TRERF1       C       0.354         0.574
  IL-15RA      A       0.435         0.624
  IL-15RA      B       0.536         0.541
  IL-15RA      C       0.467         0.694
  TLR8         A       0.178         0.435
  TLR8         B       0.268         0.458
  TLR8         C       0.178         0.482
  LRRK2        A       0.067         0.537
  LRRK2        B       0.117         0.553
  LRRK2        C       0.058         0.482

Data show the mean (log
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Second, beyond validation with original microarray samples, we tested whether there would be similar changes in gene expression in MDMs from additional human blood donors. Selected transcripts that were validated by RT-qPCR are shown in **Figure [3](#F3){ref-type="fig"}**, showing down-modulated transcripts in panels A through H, and up-regulated transcripts in panels I through L. Although some of the minimally changed did not reach significance compared to uninfected MDMs, the overall directions of changes were concordant between data from new donors and original microarray results.

![qPCR validation of changes in gene expression observed on microarrays. Validation performed using RNA samples of additional blood donors different than those included in microarray analysis shown in **Figure [2](#F2){ref-type="fig"}**. **(A--H)** Shows RT-qPCR of selected MDM transcripts whose expression was down-regulated, according to Affymetrix microarrays. **(I--L)** Shows RT-qPCR of selected MDM transcripts whose expression was up-regulated. Data consist in the average fold change elicited by each *L. braziliensis* clade representative relative to uninfected MDMs from the same donor.](fmicb-09-02464-g003){#F3}

MDM Transcripts Regulation According to Infection With *L. braziliensis* Clade
------------------------------------------------------------------------------

Transcripts of MDMs infected with *L. braziliensis* isolates belonging to each of the three different clades were regulated in the same general direction (induction/repression). However, the magnitude of change for many transcripts differed between the clades (**Figure [4](#F4){ref-type="fig"}**). Aggregate analysis of the MDM gene expression profiles, employing the built-in clustering capability of the Partek Genomics Suite (Partek, Inc., Chesterfield, MO, United States), was used to compare changes in gene expression induced by infection with parasite strains associated with metastatic diseases \[clades A (DL), C (ML)\] and with localized CL (clade B). As illustrated in **Figure [4A](#F4){ref-type="fig"}**, the overlap between transcripts significantly altered by infection with clades C and A was greater than the overlap between either clades C and B or clades A and B. The magnitude by which each of the parasite isolates suppressed the 471 down-modulated transcripts is plotted according to clade in **Figure [4B](#F4){ref-type="fig"}**. Although all changes were in the same direction, the plot illustrates that the magnitude of change was similar between isolates belonging to clades A and C, and both were more intense than changes induced by the clade B isolate. The difference between the suppressive effects of parasite isolates on gene expression was statistically significant (**Figure [4B](#F4){ref-type="fig"}**, Friedman's test, *p* = 0.002; **Figure [2](#F2){ref-type="fig"}**, ANOVA, *p* \< 0.0001).

![Gene expression profiles from the microarrays described and illustrated in **Figure [2](#F2){ref-type="fig"}** were collated according to the number of significantly altered transcripts in MDM infected with isolates from each of the three representatives of *L. braziliensis* clades (A, B, or C). **(A)** Venn diagram of the distribution of transcripts with changes in expression that reached statistical significance upon infection of MDMs with each *L. braziliensis* parasite. Sectors indicate the numbers of transcripts that were uniquely changed due to infection with one parasite clade, or transcripts that were changed by infection with more than one parasite clade (evaluation of gene expression employed ANOVA for detecting transcripts significantly affected by infections, and paired Student's *t*-test for comparing the expression elicited by clades of parasites in infected MDM). **(B)** The magnitude of change in expression of 471 genes in MDM infected with each of the three *L. braziliensis* isolates is illustrated. Values represent the fold changes in expression of the 471 genes for which transcript abundance was significantly decreased by infection with any of the three parasite isolates tested. *L. braziliensis* isolates belong to clade A (DL; blue), clade B (CL; green), or clade C (ML; red). Each position on the x-axis corresponds to a single gene, plotted against its fold change in expression on the y-axis (Friedman's test *p* \< 0.002 for pair-wise comparisons between MDM infected with different parasite clades).](fmicb-09-02464-g004){#F4}

We questioned whether additional parasite isolates belonging to clades A, B, or C would yield the same or different effects on macrophage gene expression. MDMs from eight new subjects were infected in parallel with nine *L. braziliensis* isolates, including three isolates from each of the three clades A, B, or C, respectively. The average fold changes in two of the most down-regulated transcripts (LRRK2 and TLR8) and two of the most up-regulated transcripts (HSPA1A and MT1M) were determined by RT-qPCR. In each case, the direction of fold change in MDMs from the new donors to a larger set of parasite isolates was similar to that observed in the original MDMs responding to the initial three parasite isolates (**Figure [5](#F5){ref-type="fig"}**). Furthermore, in each case the changes induced by clades A and C isolates were similar to each other, but different from changes induced by clade B (**Figure [5](#F5){ref-type="fig"}**).

![Changes in LRRK2, TLR8, HSPA1A, and MT1M expression were documented in independent assays of MDMs from eight additional human donors, distinct from those of experiments depicted in **Figures [1](#F1){ref-type="fig"}**--**[4](#F4){ref-type="fig"}**. MDMs were infected with three representative *L. braziliensis* isolates of each clade (A, B, or C) used in microarray experiments. Data derived from total RNA extracted after 4 h of MDM infection at a MOI of two parasites per macrophage (2:1). The relative abundance of transcripts was assessed by RT-qPCR. *p*-Values correspond to pair-wise comparisons by one tailed paired Wilcoxon test.](fmicb-09-02464-g005){#F5}

Kinetics of Selected Transcripts in Infected MDM
------------------------------------------------

We evaluated the duration of change in expression of twenty significantly affected MDM genes up to 48 h post-infection of MDM from eight different donors. The transcripts were chosen to reflect the range of expressions detected by the micro array experiments. These data, shown in **Table [3](#T3){ref-type="table"}**, indicate that the changes in expression of the chosen transcripts peaked at either 4 or 24 h. Considering all transcripts and all time points tested, the following transcripts reached significance: IL10RB, MYD88H, TRERF1, PARK7, UBC, MT1M, NDUFA11, and NUP214. Biological relevance would require a secondary study of protein abundance, but these data lead us to conclude that the kinetics of gene expression is dynamic over the first 48 h after macrophage infection, and that at least some transcripts reaching signficance at 4 h remained elevated or suppressed at 24 h.

###### 

Expression kinetics of 21 transcripts significantly induced or repressed in human monocyte derived macrophages of eight donors after 4 h infection with an *L. braziliensis* isolate of a cutaneous leishmaniasis patient from Corte de Pedra, Brazil.

  Transcript   4 h Mean (SE)   24 h Mean (SE)   48 h Mean (SE)   4 h × 24 h × 48 h *p*-value   4 h × 24 h *p*-value   4 h × 48 h *p*-value
  ------------ --------------- ---------------- ---------------- ----------------------------- ---------------------- ----------------------
  LRRK2        0.44 (0.11)     0.64 (0.19)      0.30 (0.09)      0.2637                        0.3751                 0.3565
  NUP214       0.55 (0.07)     1.17 (0.10)      0.86 (0.21)      0.0162\*                      0.0008\*\*\*           0.1407
  TRERF1       0.55 (0.11)     1.58 (0.40)      1.01 (0.27)      0.1443                        0.0484\*               0.1874
  TP53         0.60 (0.10)     0.88 (0.15)      0.73 (0.19)      0.3708                        0.1747                 0.6276
  IL10RB       0.60 (0.13)     1.18 (0.09)      0.53 (0.17)      0.0395\*                      0.0087\*\*             0.8201
  MAPK14       0.62 (0.12)     0.89 (0.21)      0.71 (0.17)      0.3497                        0.2053                 0.6732
  TLR8         0.68 (0.15)     1.23 (0.29)      0.53 (0.18)      0.1667                        0.2021                 0.4237
  NDUFA11      0.70 (0.08)     2.11 (0.57)      0.57 (0.19)      0.0490\*                      0.0430\*               0.5232
  PARK7        0.73 (0.05)     1.23 (0.07)      0.76 (0.19)      0.0304\*                      0.0001\*\*\*           0.8683
  XPO6         0.77 (0.10)     1.56 (0.47)      0.94 (0.30)      0.2905                        0.1462                 0.6111
  MYD88H       0.85 (0.11)     1.64 (0.26)      0.68 (0.17)      0.0104\*                      0.0384\*               0.4681
  FRP1         0.86 (0.27)     1.61 (0.26)      0.94 (0.23)      0.1498                        0.1212                 0.8445
  NUP93        1.02 (0.24)     1.06 (0.05)      0.98 (0.23)      0.9414                        0.8573                 0.9014
  IL15RA       1.32 (0.40)     1.37 (0.28)      0.92 (0.22)      0.5385                        0.9363                 0.4214
  NUB1         1.35 (0.37)     2.40 (0.56)      0.86 (0.27)      0.0929                        0.2262                 0.3887
  UBC          1.39 (0.30)     3.27 (0.82)      0.77 (0.21)      0.0244\*                      0.0154\*               0.1336
  TXRND1       1.85 (0.28)     2.44 (0.68)      0.87 (0.25)      0.0621                        0.3381                 0.0730
  MT1X         2.66 (0.69)     1.50 (0.30)      1.24 (0.41)      0.1087                        0.1084                 0.1095
  MT1M         3.20 (0.71)     3.25 (1.04)      0.78 (0.29)      0.0214\*                      0.9564                 0.0058\*\*
  HSPA1A       4.45 (2.14)     2.84 (0.90)      2.43 (1.44)      0.6523                        0.5278                 0.5245

Statistical comparisons of three time points were done by ANOVA; comparisons between two times utilized Student's

t

-test.
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Discussion
==========

Previous studies have directly or indirectly underscored the influences of both parasite and host on the clinical phenotypes of diseases caused by *L. braziliensis* ([@B33]; [@B9]; [@B59], [@B60]; [@B62], [@B61]; [@B12], [@B13]; [@B58]). In the present report, we tested whether the initial contact between human macrophages and genetically distinct *L. braziliensis* strains derived from individuals with different clinical forms of tegumentary leishmaniasis might lead to diverse gene expression patterns in the host macrophage. The *L. braziliensis* isolates we examined were chosen from representative individuals with either metastatic (disseminated or mucosal) forms of leishmaniasis, or localized (cutaneous) leishmaniasis. Each isolate had previously been typed as belonging to the three genetically distinct clades that correspond to the different forms of disease (A, C, or B, respectively) ([@B62]).

Remarkably, the parasites associated with the two forms of metastatic leishmaniasis (clades A and C) elicited changes in host macrophage gene expression that were more similar to each other than those induced by the isolate from a subject with localized cutaneous leishmaniasis (clade B). The differences primarily observed were in the magnitude of induction or repression of the affected transcripts, caused by the *L. braziliensis* from subjects with ML or DL as compared to the strain from a subject with CL.

*Leishmania braziliensis* infection down-regulated the expression of the majority of the significantly affected MDM transcripts. This is similar to the overall suppression of gene expression observed in other studies of murine and human macrophage infections with *Leishmania* spp. ([@B42]; [@B16]; [@B21]; [@B26]).

Prior work has suggested that there may be an overall suppression of pathways transducing signals from the extracellular environment in leishmania-infected macrophages. A report by Moore et al. was one of the earliest accounts indicating that *Leishmania* spp. infection of macrophages impairs the transmission of information from the macrophage surface to the nucleus ([@B46]). Subsequent reports showed that the initial contact between leishmania parasites and the host cell led to a transient activation of signaling mechanisms, but many signaling pathways are suppressed during established infection ([@B20]). Signaling through Jak/STAT and MAPK with resultant suppressed NF-κB activation are some of the most dramatically affected pathways ([@B32]; [@B7]; [@B22]; [@B6]; [@B10]; [@B43]). Changes leading to impaired regulatory mechanisms cited include protein phosphorylation state and targeting to the proteasome for degradation ([@B7]; [@B22]).

The current study also documents a general down-regulation of genes involved in transducing signals from TLRs or cytokines, all the way to the host cell nucleus. Taken together, these observations lead us to speculate that the changes in outside-inside signaling transcripts, primarily in a downward direction, creates an environment of anergy and paralyzes cellular functions just after host--cell invasion, which benefit the parasite.

Observations in the current study raise the hypothesis that infection with *L. braziliensis* may suppress or modify iron--sulfur clusters biogenesis and/or mitochondrial respiration. It remains to be seen whether subtle decreases in transcripts encoding components of Complex I is capable of affecting the generation of the electron potential at the mitochondrial inner membrane. Nonetheless evidence suggests that Complex I is involved in cellular apoptosis, and it is tempting to speculate that these changes might result in diminished mitochondrial signals leading to death of the infected cell. Indeed, the ability of *Leishmania* spp. infection to inhibit host cell apoptosis has long been recognized as a strategy promoting parasite persistence and survival ([@B47]; [@B37]; [@B57]).

Despite two reports showing that *L. major* infection of the murine RAW 264.7 macrophage cell line suppresses cytochrome c release from the mitochondrion, in part mediated by BCL-XL, preventing activation of caspases ([@B1]; [@B19]), our study did not reveal significant changes in expression of BCL-2 family members in human macrophages infected with *L. braziliensis*. However, transcripts encoding proteins involved in two major triggers of intrinsic pathway apoptosis were down-regulated. These were (1) TP53 and proteins that control its activation, stabilization, and translocation into the mitochondrion; and (2) LRRK2, which attaches to the mitochondrion and mediates apoptosis by a still poorly understood mechanism. Regarding LRRK2, SNPs in this gene are associated with the multibacillary form of human infection with *Mycobacterium leprae* ([@B68]), another intracellular pathogen.

*Leishmania braziliensis* can lead to diverse manifestations in infected humans. CL can disseminate if left undiagnosed and untreated for an extended time period or when occurring in malnourished individuals. Disseminated forms of tegumentary leishmaniasis are also more common in individuals who harbor particular polymorphic risk-associated alleles compared to other genotypes ([@B38]; [@B9]; [@B2]; [@B64]; [@B12], [@B13]; [@B40]; [@B58]). Our prior reports suggested that genetic polymorphism of the parasite itself is also associated with the diversity of diseases caused by this parasite ([@B62]; [@B53]). The current report extends our understanding by showing that *L. braziliensis* strains belonging to distinct clades lead to subtle but consistently distinct behaviors upon interaction with human MDMs. The study leads to the hypothesis that prolonged macrophage survival due to a decrease in apoptosis, and a greater suppression of the responses to external stimuli may correspond to part of the mechanism that favor dissemination.

A practical limitation of this study was that full evaluation of the effects of parasite clade on global macrophage gene expression was performed with one representative of each major clade, using biological replicates to enable statistical evaluation. We were able to improve on this by doing validation with a larger set of strains per *L. braziliensis* clade, though validation was done on a limited number of transcripts. Although logistics did not allow us to examine a larger set of strains in this report, these data do lead us to relevant hypotheses that merit validation in further studies with a larger array of parasite lines from additional infected patients. Ongoing tests must be done before there will be ample comparisons leading to the mechanisms and consequences of host cell invasion by distinct groups of *L. braziliensis* isolates.

It must be emphasized that the current study focused on genetically distinct strains of *L. braziliensis*. These findings, as well as our previous molecular epidemiology observations on the associations between *L. braziliensis* genotypes and clinical forms of ATL ([@B53]; [@B28]) undoubtedly work in concert with host genotype, health status of the host, coinfections, and epidemiologic factors to fully account for the polymorphic outcomes of infection. Examples of determinants shown to contribute different clinical phenotypes of *L. braziliensis* infection include concurrent infections ([@B44]; [@B41]), pregnancy ([@B48]; [@B27]), and the genetic background of the human host ([@B12], [@B13]).

It should also be pointed out that these observations reflect the earliest events in the host--parasite relationship, and thus the immediate handling of infection by one of its preferred host cell types. These early events can initiate parasite killing or survival, and recruitment of additional host cells to infected tissues, to name some functional effects. In addition to the changes highlighted in Section "Results," further studies could be used to probe differences that might lead to parasite dissemination versus containment at the local site. Relevant functions would include microbicidal response, survival of the infected cell, and recruitment of host cells that might promote parasite transport out of infected tissues ([@B15]; [@B25]; [@B54]). It is thus relevant that among transcripts up-regulated by infection with the "disseminating" clades A and C, but to a lesser extent clade B (localized disease), are a number of macrophage heat shock or stress response proteins, whereas transcripts relevant to inflammatory response pathways (TLR8, STAT1, TNFSF13B, SYK) in macrophages were down-regulated. These observations will warrant validation, followed by further examination of cellular interactions with respect to function of the implicated pathways. We expect that infected macrophages from chronically infected animals would present quite different patterns of gene expression, reflecting the inflammatory processes occurring in infected tissues at these time points. As there are multiple differences in the degree of transcript expression between clades A--C and clade B, we hypothesize that subtle differences in the degree of transcript suppression or stimulation may collectively contribute toward differences in disease manifestations including parasite dissemination. Finally, our observations also warrant future examination of protein abundance and/or function of the implicated pathways.

Author Contributions
====================

RS and VA performed parasite and macrophage isolation and cultivation, infection experiments, cultured cells RNA extractions, and data analyses. TB performed DNA micro array experiments and data analyses. NE standardized the macrophage culturing and differentiation in the lab, and helped in the micro array data analyses. LG and LA helped in macrophage culturing and infection experiments, and performed annotation of significantly expressed genes and pathways. LHG, PM, and EC were responsible for clinical work in the field that resulted in all isolates of *L. braziliensis* explored in the study, and were involved in the design of the research. MW and AS were responsible for team coordination, study design, data interpretation, and manuscript preparation.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This work was supported in part by US National Institutes of Health (NIH) grants R03 A167663 (AS and MW) and P50 AI-30639 (EC, MW, and AS), and by grants from the US Department of Veterans' Affairs I01BX001983 and I01BX000536 (MW). RS and VA were recipients of CAPES -- Brazil Ph.D. and MS scholarships, respectively. LG and LA were recipients of Conselho Nacional de Desenvolvimento Científico e Tecnológico -- Brazil (CNPq) scientific initiation scholarships.

We would like to deeply thank all personnel in the health post of Corte de Pedra, Teolândia, Brazil, for their careful help with patient management, and Ms. Kátia Salgado for laboratory support with parasite isolation and management. We gratefully acknowledge the outstanding contributions of VA, who passed away before submission of this manuscript.

Supplementary Material
======================

The Supplementary Material for this article can be found online at: <https://www.frontiersin.org/articles/10.3389/fmicb.2018.02464/full#supplementary-material>

###### 

Click here for additional data file.

[^1]: Edited by: Miguel Cacho Teixeira, Universidade de Lisboa, Portugal

[^2]: Reviewed by: James H. McKerrow, University of California, San Diego, United States; Herbert Leonel de Matos Guedes, Universidade Federal do Rio de Janeiro, Brazil; Anita Hilda Straus, Federal University of São Paulo, Brazil

[^3]: ^†^These authors have contributed equally to this work

[^4]: This article was submitted to Infectious Diseases, a section of the journal Frontiers in Microbiology
